Debevoise & Plimpton LLP has advised StepStone Group (“StepStone”) in a multi-asset secondary transaction with Gyrus Capital.

The transaction has provided a liquidity solution to existing investors and strategic capital to support the future growth of two strong performing assets in the healthcare and business services sectors, initially acquired by Gyrus Capital in 2019.

The two assets in question are Essential Pharma, which supplies a portfolio of over 300 products across multiple therapeutic areas, and dss+, a leading provider of specialist operations management consulting services.

For full details, see the official release here.

The Debevoise team advising StepStone was led by partner Gavin Anderson, and included partner Geoffrey Burgess, associates John Jacob, Arie Scharf and Edoardo Troina, and corporate staff attorney Helen Ho. Tax advice was provided by counsel Matthew Pincus and associate Corey Mavleos.